Akèy › Ipertiwoïdism › Kalifòni
Etid klinik pou Ipertiwoïdism nan Kalifòni
7 etid pou Ipertiwoïdism ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1111, Torrance
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07305818Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-032, Burbank
- Site-062, Huntington Beach
- Site-048, Oakland
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 17, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- AME Clinical Research, Los Angeles
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07722546Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 121, La Mesa
- Site 103, Sacramento
- Site 111, San Francisco
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1061, Huntington Beach
- Site Number - 1001, Los Angeles
- Site Number - 1047, Los Angeles
- ak 4 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-103, South Gate
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 31, 2026 · NCT06980649Evaluating an AI Tool for Detecting Thyrotoxic States
- Umesh Masharani, San Francisco
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT07017907Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.